Weekend reads: Subscription journals doomed?; Are scientists most often wrong?; “Buxom grapefruits”

The week at Retraction Watch featured an update on a Harvard lab whose PI is subject to a restraining order by one of his grad students, and the retraction of a paper that used male-only pronouns. Here’s what was happening elsewhere:

“We were devastated:” Authors retract paper after realizing they had used the wrong mice

Longtime readers of Retraction Watch may recall a 2011 post about a research team that retracted a paper after realizing that they had ordered the wrong mice. Maureen Gannon and Raymond Pasek of Vanderbilt University contacted us earlier this week to alert us to a similar case: Their retraction, earlier this month, of a 2016 paper … Continue reading “We were devastated:” Authors retract paper after realizing they had used the wrong mice

Researcher who tangled with CrossFit loses two more papers

An exercise scientist who ran a study of the CrossFit exercise program without an approved human subjects protocol has lost two more papers to retraction. Both papers were retracted on June 26 by the editors of the International Journal of Exercise Science (IJES) with the agreement of last author Steven Devor, a former professor at … Continue reading Researcher who tangled with CrossFit loses two more papers

Can a tracking system for peer reviewers help stop fakes?

The problem of fake peer reviews never seems to end — although the research community has known about it since 2014, publishers are still discovering new cases. In April, one journal alone retracted 107 papers after discovering the review process had been compromised. By tracking individual reviewers’ contributions, Publons — recently purchased by Clarivate Analytics — … Continue reading Can a tracking system for peer reviewers help stop fakes?

Author of retracted gene editing paper alleges “bullying” by former PI

In the fall of 2015, out-of-work stem cell biologist Mavi Camarasa decided she had waited long enough. It had been three years since she and a colleague were, best they could tell, the first to successfully correct the most common cystic fibrosis mutation in stem cells derived from a patient. But her former lab director, … Continue reading Author of retracted gene editing paper alleges “bullying” by former PI

Rutgers prof announces retraction on his blog

A Rutgers computer scientist is retracting conference proceedings via an unusual channel: his personal blog. On April 7, Anand Sarwate wrote that he was retracting a mathematical proof from the proceedings from the 2016 IEEE International Conference on Acoustics, Speech, and Signal Processing (ICASSP), after discovering errors that invalidated the result. He explains in the blog … Continue reading Rutgers prof announces retraction on his blog

Weekend reads: ‘Pile of dung’ republished; Diverging views on publishing negative results; Economists share regrets

The week at Retraction Watch featured an unusual warning from the New England Journal of Medicine, and the withdrawal of a paper over a fear of legal threats. Here’s what was happening elsewhere:

Does the philosophy literature have a plagiarism problem?

Philosopher Michael Dougherty doesn’t take plagiarism sitting down. Over the years, the researcher at Ohio Dominican University has tipped us off to numerous instances of plagiarism he’s spotted. And it turns out, he’s done the same thing for publishers, as well. In a new paper in Metaphilosophy, Dougherty describes his experience contacting publishers over an … Continue reading Does the philosophy literature have a plagiarism problem?

Could bogus scientific results be considered false advertising?

Could a scientific paper ever be considered an advertisement? That was the question posed to a Tokyo court, in a criminal case where prosecutors argued — at the behest of Japan’s ministry of health — that a peer-reviewed paper containing faked data should be considered “fraudulent or exaggerated advertising” under that country’s laws. In that case, … Continue reading Could bogus scientific results be considered false advertising?

Despite author’s protest, journal removes paper on emergency department prices

A journal has temporarily removed a paper showing the dramatic differences in the cost of providing emergency care that caught national attention (and some criticism from emergency care providers), despite the first author’s claims that the results are valid. The paper, published online in February by the Annals of Emergency Medicine, showed that it can cost … Continue reading Despite author’s protest, journal removes paper on emergency department prices